SPRO
Price
$1.13
Change
-$0.04 (-3.42%)
Updated
Oct 22 closing price
Capitalization
65.81M
21 days until earnings call
Intraday BUY SELL Signals
XENE
Price
$36.50
Change
+$0.55 (+1.53%)
Updated
Oct 22 closing price
Capitalization
3.53B
11 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SPRO vs XENE

SPRO vs XENE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
SPRO vs. XENE commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SPRO is a Hold and XENE is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for SPRO with price predictions
Oct 22, 2026

SPRO sees its Stochastic Oscillator ascending out of oversold territory

On October 20, 2026, the Stochastic Oscillator for SPRO moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 68 instances where the indicator left the oversold zone. In 54 of the 68 cases the stock moved higher in the following days. This puts the odds of a move higher at over 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SPRO just turned positive on October 20, 2026. Looking at past instances where SPRO's MACD turned positive, the stock continued to rise in 32 of 41 cases over the following month. The odds of a continued upward trend are 78%.

Following a +10.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where SPRO advanced for three days, in 151 of 206 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

Bearish Trend Analysis

The 10-day RSI Indicator for SPRO moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 25 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SPRO as a result. In 78 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

SPRO moved below its 50-day moving average on October 21, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SPRO crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPRO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

SPRO broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SPRO entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. SPRO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.489) is normal, around the industry mean (2.973). P/E Ratio (8.071) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (1.550) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SPRO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for XENE with price predictions
Oct 22, 2026

XENE's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for XENE turned positive on October 07, 2026. Looking at past instances where XENE's MACD turned positive, the stock continued to rise in 44 of 49 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where XENE's RSI Indicator exited the oversold zone, 21 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on XENE as a result. In 64 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.

Following a +8.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where XENE advanced for three days, in 195 of 290 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

XENE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 50-day moving average for XENE moved below the 200-day moving average on October 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XENE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.

The Aroon Indicator for XENE entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 64 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.845) is normal, around the industry mean (2.973). P/E Ratio (-7.700) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (1.930) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (588.235) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. XENE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
SPRO vs XENE: Fundamental Ratings
SPRO
XENE
OUTLOOK RATING
1..100
6575
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
74
Overvalued
PROFIT vs RISK RATING
1..100
10064
SMR RATING
1..100
4897
PRICE GROWTH RATING
1..100
6480
P/E GROWTH RATING
1..100
8811
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XENE's Valuation (74) in the Biotechnology industry is in the same range as SPRO (80) in the Pharmaceuticals Major industry. This means that XENE’s stock grew similarly to SPRO’s over the last 12 months.

XENE's Profit vs Risk Rating (64) in the Biotechnology industry is somewhat better than the same rating for SPRO (100) in the Pharmaceuticals Major industry. This means that XENE’s stock grew somewhat faster than SPRO’s over the last 12 months.

SPRO's SMR Rating (48) in the Pharmaceuticals Major industry is somewhat better than the same rating for XENE (97) in the Biotechnology industry. This means that SPRO’s stock grew somewhat faster than XENE’s over the last 12 months.

SPRO's Price Growth Rating (64) in the Pharmaceuticals Major industry is in the same range as XENE (80) in the Biotechnology industry. This means that SPRO’s stock grew similarly to XENE’s over the last 12 months.

XENE's P/E Growth Rating (11) in the Biotechnology industry is significantly better than the same rating for SPRO (88) in the Pharmaceuticals Major industry. This means that XENE’s stock grew significantly faster than SPRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SPROXENE
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
69%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
67%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 9 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
67%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
73%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (SPRO: $1.13 vs. XENE: $36.50)
Brand notoriety: SPRO and XENE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SPRO: 36% vs. XENE: 76%
Market capitalization -- SPRO: $65.81M vs. XENE: $3.53B
SPRO [@Biotechnology] is valued at $65.81M. XENE’s [@Biotechnology] market capitalization is $3.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SPRO’s FA Score shows that 0 FA rating(s) are green while XENE’s FA Score has 1 green FA rating(s).

  • SPRO’s FA Score: 0 green, 5 red.
  • XENE’s FA Score: 1 green, 4 red.
According to our system of comparison, both SPRO and XENE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SPRO’s TA Score shows that 4 TA indicator(s) are bullish while XENE’s TA Score has 5 bullish TA indicator(s).

  • SPRO’s TA Score: 4 bullish, 6 bearish.
  • XENE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, XENE is a better buy in the short-term than SPRO.

Price Growth

SPRO (@Biotechnology) experienced а 0.00% price change this week, while XENE (@Biotechnology) price change was +6.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.

Reported Earning Dates

SPRO is expected to report earnings on Nov 12, 2026.

XENE is expected to report earnings on Nov 02, 2026.

Industries' Descriptions

@Biotechnology (-1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
SPRO
Daily Signal:
Gain/Loss:
XENE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

SPRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRO has been loosely correlated with CCXI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRO jumps, then CCXI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRO
1D Price
Change %
SPRO100%
-3.42%
CCXI - SPRO
48%
Loosely correlated
-0.82%
ASBP - SPRO
42%
Loosely correlated
+1.47%
VYGR - SPRO
34%
Loosely correlated
-7.92%
JAGX - SPRO
34%
Loosely correlated
-5.70%
XENE - SPRO
32%
Poorly correlated
+1.53%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FYX138.071.45
+1.06%
First Trust Small Cap Core Alphadex Fund (FYX)
FXA69.55-0.14
-0.20%
Invesco CurrencyShares Australian Dollar Trust (FXA)
GQI60.79-0.52
-0.85%
Natixis Gateway Quality Income ETF (GQI)
TNUK20.60-0.67
-3.14%
Tortoise Nuclear Renaissance ETF
SLON31.55-3.00
-8.68%
ProShares Ultra Solana ETF (SLON)